Innovation Horizons | Pharmaceuticals
archive,category,category-pharmaceuticals,category-201,ajax_fade,page_not_loaded,,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-6.13.0,vc_responsive


We know that specialty drugs( most injectables, biologics, and drugs requiring specialized administration) are expensive but spending on specialty drugs has often been difficult to measure because of proprietary rebate payments by manufacturers to insurers, pharmacy benefit managers, and state Medicaid agencies. A recent analysis...